1. Market Research
  2. > Pharmaceutical
  3. > Drug Development Market Trends
  4. > Global Drug Development Analysis & Statistics, June 2019

Global Drug Development Analysis & Statistics, June 2019

Customer Support

Talk to Ahmad

+44 207 1931 362

1-30 of about 2900 reports

Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market - Growth, Trends, and Forecast (2019 - 2024)

Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market - Growth, Trends, and Forecast (2019 - 2024)

  • € 5920
  • Industry report
  • June 2019

Market OverviewFor the Contract Manufacturing Outsourcing (CMO), the growing demand for generic medicines and biologics, the capital-intensive nature of the business, and the complex manufacturing requirements, ...

  • Industries : Pharmaceutical
  • Countries : World, United States, North America
Protein Stability Analysis Market by Product, End User - Global Forecast to 2024

Protein Stability Analysis Market by Product, End User - Global Forecast to 2024

  • € 5044
  • Industry report
  • June 2019

Growing adoption of open innovation models in pharmaceutical & biotechnology companies is expected to drive the overall growth of the protein stability analysis market.The protein stability analysis market ...

  • Industries : Drug Development, Pharmaceutical
  • Countries : United States, North America
Cell-based Assay Market by Product, Application, End User, Geography - Global Forecast to 2024

Cell-based Assay Market by Product, Application, End User, Geography - Global Forecast to 2024

  • € 5044
  • Industry report
  • April 2019

Cell-based assays market to register a CAGR of 6.3% from 2019 to 2024The cell-based assays market is projected to reach USD 18.9 billion by 2024 from USD 13.9 billion in 2019, at a CAGR of 6.3% during ...

  • Industries : Medical Biotechnology, Diagnostics, Biotechnology, Healthcare
  • Countries : United States, North America
Global High Content Screening (HCS) Industry

Global High Content Screening (HCS) Industry

  • € 4911
  • Industry report
  • May 2019

This report analyzes the worldwide markets for High Content Screening (HCS) in US$ Million.The Global market is further analyzed by the following Segments: Consumables, Instruments, and Others. The report ...

  • Industries : Drug Development
  • Countries : World, Europe, APAC, United States, Japan
Global Therapeutic Drug Monitoring (TDM) Country Shares and Segment Forecasts 2019-2023: US, Europe (France, Germany, Italy, Spain, UK), Japan

Global Therapeutic Drug Monitoring (TDM) Country Shares and Segment Forecasts 2019-2023: US, Europe (France, Germany, Italy, Spain, UK), Japan

  • € 4824
  • Industry report
  • April 2019

Global Therapeutic Drug Monitoring (TDM) Country Shares and Segment Forecasts 2019-2023: US, Europe (France, Germany, Italy, Spain, UK), JapanThis new 313-page report contains 83 tables and provides analysis ...

  • Industries : Drug Development
  • Countries : World
Clinical Trials Management System Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

Clinical Trials Management System Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • € 4205
  • Industry report
  • April 2019

The report on the global clinical trials management system market provides qualitative and quantitative analysis for the period from 2017 to 2025.The report predicts the global clinical trials management ...

  • Industries : Drug Development
  • Countries : World
Protein Assays Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

Protein Assays Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • € 4205
  • Industry report
  • March 2019

The report on the global protein assays market provides qualitative and quantitative analysis for the period from 2017 to 2025.The report predicts the global protein assays market to grow with a CAGR of ...

  • Industries : Drug Development
  • Countries : World
Cell Encapsulation: Focus on Therapeutics and Technologies, 2019-2030

Cell Encapsulation: Focus on Therapeutics and Technologies, 2019-2030

  • € 3946
  • Industry report
  • March 2019

INTRODUCTIONChronic disorders, such as diabetes, cancer, heart disease, obesity, and certain types of mental health problems, are considered among the leading causes of death and disability across the ...

  • Industries : Pharmaceutical, Medical Biotechnology, Biopharmaceutical, Biopharmaceutical, Pathology, Therapy
  • Countries : United States, North America, World
Prostaglandin D2 Receptor 2 - Pipeline Review, H1 2019

Prostaglandin D2 Receptor 2 - Pipeline Review, H1 2019

  • € 3070
  • Company report
  • June 2019

Prostaglandin D2 Receptor 2 - Pipeline Review, H1 2019SummaryProstaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 o ...

  • Industries : Pathology, Therapy, Chronic Disease, Pharmaceutical
  • Countries : United States, World, United Kingdom
Insulin Like Growth Factor I - Pipeline Review, H1 2019

Insulin Like Growth Factor I - Pipeline Review, H1 2019

  • € 3070
  • Company report
  • June 2019

Insulin Like Growth Factor I - Pipeline Review, H1 2019SummaryAccording to the recently published report ’Insulin Like Growth Factor I - Pipeline Review, H1 2019’; Insulin Like Growth Factor I (Mechano ...

  • Industries : Therapy, Mental Health, Pathology, Pharmaceutical
  • Countries : World, United States
Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) - Pipeline Review, H1 2019

Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) - Pipeline Review, H1 2019

  • € 3070
  • Company report
  • April 2019

Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) - Pipeline Review, ...

  • Industries : Pathology, Pharmaceutical, Therapy, Drug Development
  • Countries : World, Europe, Germany, United States, North America
Rho Associated Protein Kinase 1 (Renal Carcinoma Antigen NY REN 35 or Rho Associated Coiled Coil Containing Protein Kinase 1 or p160 ROCK 1 or ROCK1 or EC 2.7.11.1) - Pipeline Review, H1 2019

Rho Associated Protein Kinase 1 (Renal Carcinoma Antigen NY REN 35 or Rho Associated Coiled Coil Containing Protein Kinase 1 or p160 ROCK 1 or ROCK1 or EC 2.7.11.1) - Pipeline Review, H1 2019

  • € 3070
  • Company report
  • April 2019

Rho Associated Protein Kinase 1 (Renal Carcinoma Antigen NY REN 35 or Rho Associated Coiled Coil Containing Protein Kinase 1 or p160 ROCK 1 or ROCK1 or EC 2.7.11.1) - Pipeline Review, H1 2019SummaryRho ...

  • Industries : Therapy, Pharmaceutical, Drug Development, Health Services
  • Countries : United Kingdom, World, United States
Retinoic Acid Receptor Beta (RAR Beta or HBV Activated Protein or Nuclear Receptor Subfamily 1 Group B Member 2 or RAR Epsilon or NR1B2 or RARB) - Pipeline Review, H1 2019

Retinoic Acid Receptor Beta (RAR Beta or HBV Activated Protein or Nuclear Receptor Subfamily 1 Group B Member 2 or RAR Epsilon or NR1B2 or RARB) - Pipeline Review, H1 2019

  • € 3070
  • Company report
  • April 2019

Retinoic Acid Receptor Beta (RAR Beta or HBV Activated Protein or Nuclear Receptor Subfamily 1 Group B Member 2 or RAR Epsilon or NR1B2 or RARB) - Pipeline Review, H1 2019SummaryRetinoic Acid Recepto ...

  • Industries : Therapy, Pharmaceutical, Pathology
  • Countries : United States, World
Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) - Pipeline Review, H1 2019

Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) - Pipeline Review, H1 2019

  • € 3070
  • Company report
  • April 2019

Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) - Pipeline Review, H1 2019SummaryAccording to the recently published report ’Retinoic Acid Recepto ...

  • Industries : Pharmaceutical, Therapy
  • Countries : United States, World
Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Pipeline Review, H1 2019

Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Pipeline Review, H1 2019

  • € 3070
  • Company report
  • April 2019

Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Pipeline Review, H1 2019SummaryNeuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Neuronal acetylcholine receptor subunit alpha-7 is a ...

  • Industries : Mental Health, Pathology, Pharmaceutical, Therapy
  • Countries : United States, World
2019 Global Therapeutic Drug Monitoring Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers

2019 Global Therapeutic Drug Monitoring Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers

  • € 3070
  • Industry report
  • April 2019

2019 Global Therapeutic Drug Monitoring Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for SuppliersThis new 313-page report ...

  • Industries : Drug Development
  • Countries : World
Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H1 2019

Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H1 2019

  • € 3070
  • Company report
  • March 2019

Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H1 2019SummaryIntegrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha o ...

  • Industries : Therapy, Pathology, Medical Biotechnology, Pharmaceutical, Biopharmaceutical, Biopharmaceutical, Oncology
  • Countries : World, United States
P2X Purinoceptor 3 (P2RX3) - Pipeline Review, H1 2019

P2X Purinoceptor 3 (P2RX3) - Pipeline Review, H1 2019

  • € 3070
  • Company report
  • March 2019

P2X Purinoceptor 3 (P2RX3) - Pipeline Review, H1 2019SummaryP2X Purinoceptor 3 (P2RX3) pipeline Target constitutes close to 14 molecules. Out of which approximately 13 molecules are developed by companies ...

  • Industries : Pharmaceutical, Therapy, Drug Development
  • Countries : United States, World
Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) - Pipeline Review, H1 2019

Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) - Pipeline Review, H1 2019

  • € 3070
  • Company report
  • March 2019

Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) - Pipeline Review, H1 2019SummaryIntercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) ...

  • Industries : Healthcare, Therapy, Pharmaceutical, Pathology
  • Countries : United States, World
Hepatitis B: Competitive Landscape to 2027

Hepatitis B: Competitive Landscape to 2027

  • € 3065
  • Industry report
  • May 2019

Hepatitis B: Competitive Landscape to 2027SummaryHepatitis B is a viral infection of the liver that can become chronic in young children, especially newborns to mothers with HBV infections, and people ...

  • Industries : Pathology, Drug Development, Pharmaceutical, Healthcare
  • Countries : United States, China, World
North America Contract Research Organization Market to 2025 - Regional Analysis and Forecasts by Type ; End User, and Country

North America Contract Research Organization Market to 2025 - Regional Analysis and Forecasts by Type ; End User, and Country

  • € 2631
  • Industry report
  • April 2019

The North America contract research organization (CRO) market is expected to reach US$ 30,730.1 Mn in 2025 from US$ 16,369.3 Mn in 2017. The market is estimated to grow with a CAGR of 8.4% from 2018-2025.The ...

  • Industries : Drug Development, Pharmaceutical
  • Countries : North America
2019 Global Therapeutic Drug Monitoring (TDM) Market: US, Europe, Japan--US, Europe, Japan--Supplier Shares, Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review

2019 Global Therapeutic Drug Monitoring (TDM) Market: US, Europe, Japan--US, Europe, Japan--Supplier Shares, Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review

  • € 2368
  • Industry report
  • April 2019

2019 Global Therapeutic Drug Monitoring (TDM) Market: US, Europe, Japan--US, Europe, Japan--Supplier Shares, Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation ...

  • Industries : Drug Development
  • Countries : World, United States, Europe, Japan
GLOBAL CLINICAL TRIAL MANAGEMENT MARKET FORECAST 2019-2027

GLOBAL CLINICAL TRIAL MANAGEMENT MARKET FORECAST 2019-2027

  • € 2250
  • Industry report
  • April 2019

KEY FINDINGSGlobal clinical trial management (CTM) market is estimated to grow with approx. 11.12% CAGR during the year 2019-2027 and is expected to gain $XX million till the year 2027. Clinical trial ...

  • Industries : Drug Development
  • Countries : World
Peripherally Inserted Central Catheter (PICC) Devices - Medical Devices Pipeline Assessment, 2019

Peripherally Inserted Central Catheter (PICC) Devices - Medical Devices Pipeline Assessment, 2019

  • € 2193
  • Industry report
  • May 2019

Peripherally Inserted Central Catheter (PICC) Devices - Medical Devices Pipeline Assessment, 2019SummaryGlobalData’s Medical Devices sector report, “Peripherally Inserted Central Catheter (PICC) Devices ...

  • Industries : Drug Delivery, Pharmaceutical
  • Countries : United States, World, North America
Cytopenia Global Clinical Trials Review, H1, 2019

Cytopenia Global Clinical Trials Review, H1, 2019

  • € 2193
  • Industry report
  • April 2019

Cytopenia Global Clinical Trials Review, H1, 2019SummaryGlobalData’s clinical trial report, “Cytopenia Global Clinical Trials Review, H1, 2019" provides an overview of Cytopenia clinical trials scenario.This ...

  • Industries : Therapy, Pharmaceutical
  • Countries : World
Crohn’s Disease (Regional Enteritis) Global Clinical Trials Review, H1, 2019

Crohn’s Disease (Regional Enteritis) Global Clinical Trials Review, H1, 2019

  • € 2193
  • Industry report
  • April 2019

Crohn’s Disease (Regional Enteritis) Global Clinical Trials Review, H1, 2019SummaryGlobalData’s clinical trial report, “Crohn’s Disease (Regional Enteritis) Global Clinical Trials Review, H1, 2019" ...

  • Industries : Therapy, Pharmaceutical
  • Countries : World
Coronary Disease Global Clinical Trials Review, H1, 2019

Coronary Disease Global Clinical Trials Review, H1, 2019

  • € 2193
  • Industry report
  • April 2019

Coronary Disease Global Clinical Trials Review, H1, 2019SummaryGlobalData’s clinical trial report, “Coronary Disease Global Clinical Trials Review, H1, 2019" provides an overview of Coronary Disease ...

  • Industries : Pharmaceutical, Drug Development, Chronic Disease, Pathology, Therapy
  • Countries : World
Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Global Clinical Trials Review, H1, 2019

Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Global Clinical Trials Review, H1, 2019

  • € 2193
  • Industry report
  • April 2019

Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Global Clinical Trials Review, H1, 2019SummaryGlobalData’s clinical trial report, “Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) Global ...

  • Industries : Therapy, Pharmaceutical, Drug Development, Cancer, Pathology
  • Countries : World
Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, H1, 2019

Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, H1, 2019

  • € 2193
  • Industry report
  • April 2019

Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, H1, 2019SummaryGlobalData’s clinical trial report, “Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, ...

  • Industries : Therapy, Pharmaceutical
  • Countries : World
Cirrhosis Global Clinical Trials Review, H1, 2019

Cirrhosis Global Clinical Trials Review, H1, 2019

  • € 2193
  • Industry report
  • April 2019

Cirrhosis Global Clinical Trials Review, H1, 2019SummaryGlobalData’s clinical trial report, “Cirrhosis Global Clinical Trials Review, H1, 2019" provides an overview of Cirrhosis clinical trials scenario.This ...

  • Industries : Therapy, Pharmaceutical
  • Countries : World

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on